Qualigen Therapeutics (QLGN) Stock Chart & Stock Price History $1.90 0.00 (0.00%) Closing price 03:59 PM EasternExtended Trading$1.94 +0.04 (+2.11%) As of 04:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Qualigen Therapeutics Stock Price Performance The Qualigen Therapeutics (QLGN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 80.43%, with a year-to-date return of -54.87%. In the past month, the stock has decreased 36.88%, reflecting recent market activity. As of the latest close, Qualigen Therapeutics traded at $1.90 with a market cap of $3.12 million and volume of 99,080 shares. Five years ago, the stock traded at a split-adjusted price of $280.00, representing a 99.32% decrease over that period. At the time, it had a market cap of $106.21 million and a volume of 57,511 shares. Receive QLGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Qualigen Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+13.77%1 Month Performance-36.88%3 Month Performance-50.90%Year-To-Date Performance-54.87%1 Year Performance-80.43%5 Year Performance-99.32% QLGN Stock Chart for Monday, August, 18, 2025 QLGN Chart by TradingView Qualigen Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/15/2025$1.76$1.90+7.95%$1.93$1.7199,080 shs$3.12 million08/14/2025$1.67$1.76+5.39%$1.80$1.6745,312 shs$2.89 million08/13/2025$1.68$1.67-0.60%$1.70$1.6169,999 shs$2.74 million08/12/2025$1.73$1.68-2.89%$1.75$1.6730,075 shs$2.76 million08/11/2025$1.82$1.73-4.95%$1.82$1.7127,948 shs$2.84 million08/08/2025$1.85$1.82-1.62%$1.91$1.7572,472 shs$2.99 million08/07/2025$1.76$1.85+5.11%$1.90$1.7639,367 shs$3.03 million08/06/2025$1.90$1.76-7.37%$1.95$1.7683,155 shs$2.89 million08/05/2025$2.07$1.90-8.21%$2.07$1.89145,291 shs$3.12 million08/04/2025$2.17$2.07-4.61%$2.13$2.0273,558 shs$3.38 million Get the Latest News and Ratings for QLGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Qualigen Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/01/2025$2.20$2.17-1.36%$2.20$2.0033,591 shs$3.55 million07/31/2025$2.52$2.20-12.70%$2.48$2.20144,900 shs$3.61 million07/30/2025$2.52$2.52$2.59$2.4930,093 shs$4.13 million07/29/2025$2.80$2.52-10.00%$2.71$2.46179,951 shs$4.12 million07/28/2025$2.80$2.80$2.98$2.58438,051 shs$4.59 million07/25/2025$2.97$2.80-5.63%$2.97$2.7495,380 shs$4.59 million07/24/2025$2.95$2.97+0.58%$3.05$2.88157,234 shs$4.87 million07/23/2025$3.00$2.95-1.67%$3.09$2.91236,972 shs$4.82 million07/22/2025$3.07$3.00-2.28%$3.13$2.88138,096 shs$4.92 million07/21/2025$3.01$3.07+1.99%$3.29$2.77344,424 shs$5.04 million07/18/2025$3.26$3.01-7.67%$3.20$3.00380,747 shs$4.94 million07/17/2025$3.93$3.26-17.05%$4.00$3.16926,050 shs$5.35 million Related Companies FLGC Stock Chart GOVX Stock Chart PHXM Stock Chart LGVN Stock Chart HOOK Stock Chart SNPX Stock Chart TAOX Stock Chart XFOR Stock Chart PHIO Stock Chart IBIO Stock Chart Receive QLGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Qualigen Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:QLGN) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qualigen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Qualigen Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access